Difference between revisions of "Part:BBa K3714010"

Revision as of 02:24, 22 October 2021

Improved gard-337 for lateral flow assay

To test our optimized design with TMSD(toehold mediated strand displacement) reaction, a toehold site between biotin probe binding site and aptazyme domain is necessary. However, designing the probe manually and testing with available RNA structure prediction model is a huge work with consuming much labor.
This part was designed by our probe design model and verified by the prediction model of team: SJTU-Software. And the changed sequences shows no influence on the function of aptazyme, the toehold worked as our expect as well (Figure.1).
The stop oligo significantly in

Figure.1 | Verification of temporarily inhibition and disinhibition by oligonucleotides. The aptazyme was produced by a T7 in vitro transcription system. The product was run on a denatured PAGE. Gardiquimod is an inhibitor of the cleavage activity and "-gardiquimod" is a control group. "stop" and "start" are two oligonucleotides designed to control the activity of the aptazyme/

Sequence and Features

Assembly Compatibility:

10
COMPATIBLE WITH RFC[10]
12
COMPATIBLE WITH RFC[12]
21
COMPATIBLE WITH RFC[21]
23
COMPATIBLE WITH RFC[23]
25
COMPATIBLE WITH RFC[25]
1000
COMPATIBLE WITH RFC[1000]

@@ Line 3: / Line 3: @@
 <partinfo>BBa_K3714010 short</partinfo>
-To test our optimized design with TMSD(toehold mediated strand displacement) reaction, a toehold site between biotin probe binding site and aptazyme domain is necessary. However, designing the probe manually and testing with available RNA structure prediction model is a huge work with consuming much labor.
+To test our optimized design with TMSD(toehold mediated strand displacement) reaction, a toehold site between biotin probe binding site and aptazyme domain is necessary. However, designing the probe manually and testing with available RNA structure prediction model is a huge work with consuming much labor. <br/>
-This part was designed by our probe design model and verified by the prediction model of team: SJTU-Software. And the changed sequences shows no influence on the function of aptazyme, the toehold worked as our expect as well (Figure.1).
+This part was designed by our probe design model and verified by the prediction model of team: SJTU-Software. And the changed sequences shows no influence on the function of aptazyme, the toehold worked as our expect as well (Figure.1). <br/>
+The stop oligo significantly in
+<br/>
+<center>[[File:K3714016.png]]</center>
+<center><b>Figure.1 | Verification of temporarily inhibition and disinhibition by oligonucleotides. </b>The aptazyme was produced by a T7 <i>in vitro</i> transcription system. The product was run on a denatured PAGE. Gardiquimod is an inhibitor of the cleavage activity and "-gardiquimod" is a control group. "stop" and "start" are two oligonucleotides designed to control the activity of the aptazyme/</center>
 <!-- Add more about the biology of this part here
@@ Line 12: / Line 16: @@
 <span class='h3bb'>Sequence and Features</span>
 <partinfo>BBa_K3714010 SequenceAndFeatures</partinfo>
-<br/>
-<center>[[File:K3714016.png]]</center>
-<center><b>Figure.1 | Verification of temporarily inhibition and disinhibition by oligonucleotides. </b>The aptazyme was produced by a T7 <i>in vitro</i> transcription system. The product was run on a denatured PAGE. Gardiquimod is an inhibitor of the cleavage activity. "stop" and "start" are two oligonucleotides designed to control the activity of the aptazyme/</center>
 <!-- Uncomment this to enable Functional Parameter display
 ===Functional Parameters===
 <partinfo>BBa_K3714010 parameters</partinfo>
 <!-- -->